Release Date: 21/10/19 08:22 Summary: Partly Paid Shares - Forfeiture Price Sensitive: No Download Document 105.76KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%